• Author Index
• Abstract Index
• Subject Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

G
Gabazza E. C.	-	C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Gabazza E. C.	-	Decreased expression of protein C inhibitor in renal cell carcinoma cells is partly caused by DNA methylation
Gabi K.	-	Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
	-	Age but not the presence of cancer predicts impairment of the protein C pathway in surgical patients
Gachet C.	-	A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
	-	Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
	-	PLC g-dependent GPIb signaling following platelet adhesion to von Willebrand factor through a pathway distinct from FcR g chain and FcgRIIA
	-	A key role of the fast ATP-gated P2X1 cation channel in the thrombosis of small arteries in vivo
	-	The role of the P2Y1, P2Y12, and P2X1 platelet receptors in a laser-induced model of arterial thrombosis in vivo
	-	Evidence for a PLCg2-independent alpha2beta1-triggered signalling pathway contributing to platelet aggregation in response to collagen
Gachet C.	-	ADP receptors and signaling pathways
Gadan C.	-	Inherited risk factors are different in pregnant and nonpregnant women with venous thromboembolism
Gadelha T.	-	Ligneous conjunctivitis: report of two cases
Gage B. F.	-	Effect of age on the incidence of venous thromboembolism after surgery
Gagnon D.R.	-	The Veterans Affairs Cooperative Studies Program's ‘80+ Hemorrhagic Cohort Study
Gago T.	-	Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
Gahmberg C. G.	-	LDL-receptor related protein (LRP) interacts with leukocyte integrin CD11b/CD18: a novel pathway in inflammatory regulation?
Gaich C.	-	Antithrombin-mediated inhibition of factor IXa by synthetic oligosaccharides
Gaidano G. L.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Gaido F.	-	Prolonged APTT children undergoing elective tonsillectomy
Gailani D.	-	Eleven novel mutations in non-Jewish factor XI deficient kindreds detected by SSCP with heteroduplex analysis followed by sequencing
Gaillard M.-C.	-	Ethnic differences in the frequencies of polymorphisms of protein S and protein C in South African populations
Gaines A.	-	Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Galajda P.	-	TAFI and diabetic nephropathy
Galán A. M.	-	Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model
Galanakis D.	-	Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Galanopoulos A.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Galantino P.	-	Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women
Gale A. J.	-	A novel engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa
Gale A. J.	-	Characterization of a thrombomodulin binding site on protein C and its distinction from an activated protein C binding site for factor Va
Gale Z.	-	Conditioning of endothelial cells by different levels of fluid shear stress modulates their ability to induce each stage of neutrophil adhesion and migration in response to TNF-a but not IL1-b
Gale A. J.	-	Characterization of the anti-apoptotic effect of activated protein C
	-	Neutral and charged lipids in factor Va inactivation
Galiani D.	-	Utility of PFA-100 in pediatric patients referred for evaluation of bleeding symptoms
Galich A.	-	Insulin resistance status and truncal fat are important determinants of plasminogen activator inhibitor type-1 (PAI-1) levels in HIV infected patients
Galitzine M.	-	A new evidence of a relationship between store-operated calcium entry and the regulation of procoagulant phosphatidylserine exposure at the surface of stimulated cells
	-	The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Galle C.	-	Phenotype of T cells in human abdominal aortic aneurysm
Galli M.	-	IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
Gallimore M. J.	-	Preparations of beta-2 glycoprotein I contain plasma kallikrein
	-	Urokinase induced fibrinolysis in thromboelastography (UKIFTEG): a new assay for determining fibrinolysis in whole blood
Gallimore M.	-	Contact system activation, FXIIa and plasma kallikrein produce enhanced fibrinolysis in urokinase induced fibrinolysis in thromboelastography: (UKIFTEG)
Gallistl S.	-	Hemostatic risk factors, metabolic control, and microalbuminuria in diabetes mellitus type 1
Gallistl S.	-	Low inhibitor levels allow fast and sufficient thrombin generation in tissue factor-activated cord plasma
Gallmeier G. U.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
	-	Comparison of two methods to assess platelet activation during and after CABG
Gallo R.	-	Inter-individual variability in inhibition of platelet activation and aggregation by clopidogrel
Gallus A.	-	A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus study
Gallus A .	-	Screening for asymptomatic deep vein thrombosis after major orthopedic surgery: findings of the Global Orthopaedic Registry (GLORY)
Gallus A.	-	Prophylactic warfarin in clinical practice. Treatment intensity when warfarin is used to prevent VTE after major joint surgery: findings from the Global Orthopedic Registry (GLORY)
Gallus A.	-	Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
	-	Duration of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: findings from the global orthopedic registry (GLORY)
Gallus A. S.	-	Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (artemis)
Galster H.	-	Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Galstyan G. M.	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Galstyan G.	-	Use of recombinant activated factor VII (rFVIIa) for management of postoperative bleeding in patients with idiopathic thrombocytopenic purpura (ITP)
Galtsjan G. M.	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Galvez A.	-	Temporal patterns and clinical outcomes in patients with heparin – induced thrombocytopenia
Gamba G.	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Gambino A.	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Gammeltoft S.	-	Anti-apoptotic effect of coagulation factor VIIa
Gan T. E.	-	Secondary thromboprophylaxis program assessing the efficacy of mini dose warfarin and prothrombin fragment 1 + 2 in selected high risk patients with venous thromboembolism
Gandelin C.	-	Frequency and effects of cytochrome P450 2C9 polymorphisms in 61 patients treated by warfarin
	-	Prethrombotic biological markers in congenital thrombophilic patients. Preliminary results of a randomized long-term secondary prophylaxis study using warfarin and comparing two INR target ranges
Gandini G.	-	Efficacy of Haemate P in the management of patients with von Willebrand disease undergoing surgery
Gandrille S.	-	ADP-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
Gane P.	-	Glycoxidation products and S100 calgranulin binding to RAGE induce tissue factor production
Gangliano-Decesare T.	-	Successful outcome of rituximab therapy for spontaneous refractory high titer FVIII inhibitors
Ganser A.	-	New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
	-	A mutation leading to a stop codon in the FVIII gene is the cause of severe canine Hemophilia A
Gao W. Q.	-	The frequency of P475S polymorphism in von Willebrand factor-cleaving protease among Chinese population and its relevance to arterial thrombotic disorders
Gao G. P.	-	Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Garagiola I.	-	A 3' untranslated region (3' UTR) variation on the factor VII (FVII) gene changes completely the phenotype due to the Arg277Cys mutation in a patient with Type I FVII deficiency
Garagiola I.	-	Analysis of the molecular mechanism of factor VII (FVII) deficiency caused by IVS2 + 1 donor splice sites mutation by ‘Exon Trapping System’ technique
Garand M.	-	Molecular dissection of the human TAFI promoter
Garcia A.	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Garcia R.	-	Recombinant human Factor XIII decreases gut ischemia reperfusion injury in the rat
Garcia P. F.	-	Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Garcia R. A.	-	Evaluation of skeletal muscle perfusion in a hindlimb ischemia model using 99 mTc-sestamibi scintigraphy
Garcia D.	-	Bridging therapy for mechanical heart valves: a model comparing unfractionated and low molecular weight heparin
Garcia Arias-Salgado E.	-	The scaffold function of b3 integrins regulates integrin signaling
García De Frutos P.	-	Gas6
Garcia de Frutos P.	-	Human vitamin K-dependent Gas6 gene: exon–intron structure and identification of allelic variants
Garcia De La Torre I.	-	OxiLDL/b2GPI complexes are frequent in SLE whereas autoantibodies to oxLig-1/b2GPI are more prevalent in patients with antiphospholipid syndrome
García De Yébenes J.	-	Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
Garcia Escobar I.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Garcia Ojalvo A.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
García-Criado M. A.	-	Polymorphisms of platelet glycoproteins Ib-a and Ia/IIa: relationship with early arteriosclerosis and arterial thrombosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
Garcia-Herola A.	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Garcia-Osuna T.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
García-Osuna T.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Garcia-Valladares I.	-	OxiLDL/b2GPI complexes are frequent in SLE whereas autoantibodies to oxLig-1/b2GPI are more prevalent in patients with antiphospholipid syndrome
Gardiner C.	-	A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
	-	Activated protein C resistance (APCR) and combined oral contraceptives: acquired APCR is more pronounced in women receiving desogestrel containing COCs than those containing levonorgestrel and is associated with low protein S levels
Gardner J.	-	Fatal pulmonary embolism in medical patients
Gare J. - P.	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Garewal G.	-	Prevalence of factor V Leiden and FV HR2 haplotypes as risk factors for deep vein thrombosis: a study from north India
Garin G.	-	Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
	-	Structural and functional characterization of a new transcription factor (6A3-5) potentially implicated in changes of smooth muscle cells phenotype
Garmy-Susini B.	-	The protective effect of estradiol is dependent on immune system for spontaneous atherosclerosis but not for injury-induced atherosclerosis
Garner S.	-	The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Garner S. F.	-	Teicoplanin-dependent platelet antibodies as a cause of severe thrombocytopenia
Garner S. F.	-	Platelet CD109: evidence for a transmembrane homologue on monocytes?
	-	Human glycoprotein VI: identification and blockade of the collagen-binding surface
Gartner T. K.	-	aIIbb3 activation by botrocetin/vWf is ADP or TXA2 dependent and the resulting aIIbb3 outside-in signaling is the major trigger for subsequent granule release and TXA2 production
	-	The peptide LSARLAF causes platelet aggregation through PLCg2 and can induce platelet activation independent of GPIIbIIIa
	-	The peptide LSARLAF directly induces a conformation change in the platelet integrin aIIbb3
Gasper S. R.	-	Cross–species interactions of FXIII and fibrinogen
Gasper S.	-	Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Gatta G.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Gattone M.	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
Gaugler M. H.	-	Irradiated endothelial cells promote platelet aggregates at high wall shear rate
Gaussem P.	-	Tissue Factor-603 A–G promoter polymorphism is associated with human monocyte constitutive but not with LPS induced gene expression
	-	ADP-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
Gautier P.	-	Acquired von Willebrand Syndrome: four cases associated with monoclonal gammopathy
	-	Comparison of FVIII levels as venous thrombosis risk factor measured by a chromogenic and a coagulant assay
Gavalaki M.	-	Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
Gavasso S.	-	Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
	-	Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
	-	The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
	-	The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
Gavazova S.	-	Assay of the von Willebrand factor propeptide in patients with type 1 von Willebrand disease (VWD) and the identification of patients with a S2179F mutation in the D4 region of von Willebrand factor
Gavrilova E. B.	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Gavrilova A. V.	-	Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Gawaz M.	-	Novel role for the membrane-bound chemokine fractalkine as a pathophysiologically relevant mechanism in platelet activation and adhesion
Gazzaniga P. P.	-	Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
	-	Antioxidant effect of wine in human: role of polyphenols
Gazzini A.	-	Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
	-	Emerging prognostic factors in ischemic heart disease
Gear A. R. L.	-	Hypochlorous acid-oxidized LDL rapidly induces platelet aggregation in the presence of low levels of ADP, thrombin, epinephrine and chemokines
Gear A. R. L.	-	Release of chemokines by monocytes and endothelial cells upon exposure to Shiga toxin and LPS: potential roles in platelet activation
Gear A. R. L.	-	Shiga toxin interactions with platelets: differential effects of anti-coagulants and platelet isolation procedures
Gear A.R.L.	-	Autophosphorylation of focal adhesion kinase at Tyr397 in collagen-stimulated human platelets
Gebbia N.	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
Gebbink M. F. B. G.	-	Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Gebska M.	-	Heparin neutralising agents instigate the binding of heparin to live cells
Gebska M.	-	High affinity heparin binding proteins are exposed on the surface and microvesicles of TF bearing cells and diminish heparin-mediated anticoagulation
Geerts W.	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
	-	Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
Geertzen H. G. M.	-	Factor VIII expression in liver disease
Geidel K.	-	Transfusion of activated platelets: increase of platelet-leukocyte binding in vivo
Geisen C.	-	Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Geishofer G.	-	Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
Geka F.	-	Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
Gellekink H.	-	Contribution of genetic factors to mild hyperhomocysteinemia
	-	Effect of the methionine synthase reductase A66G polymorphism on total homocysteine levels and venous thrombosis risk
Gelosa P.	-	Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
Gemmati D.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Gence D.	-	A prospective randomized study to assess the usefulness of venous compression ultrasonography (CUS) and plasma d-dimer (DD) assay in the decision to discontinue treatment with a vitamin K antagonist (VKA) after an acute deep-vein thrombosis (DVT)
Geng Y. - J.	-	Inhibition of 3-Hydroxy-3-methylglutaryl coenzyme-A reductase attenuates expression of inducible nitric oxide synthase in cardiac myoblasts – Possible link to direct myocardial protection during ischemia-reperfusion
Gennari L. C.	-	Behaviour of the protein C (PC)/protein S (PS) ratio in patients with thrombosis
Gennari L.	-	Influence of factor VIII (fVIII) levels in patients treated with DDAVP on the activated protein C resistance (APCR)
Gennari L.	-	Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
Gennari L. C.	-	Anti-phospholipid antibodies and hyperhomocysteinemia: response to therapy with folic acid
	-	Fibrinolytic activity and response to venous occlusion in activated protein C resistance phenotype
	-	Effects of factor VIII (fVIII) levels and activated partial thromboplastin time (aPTT) in activated protein C resistance (APC-R) ratio using two different methods
Gensini G.F.	-	Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
Gensini G. F.	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Gensini G.F.	-	Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Gensini G. F.	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Gensini F.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Gensini G. F.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
	-	Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
Gensini F.	-	High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
Gensini G. F.	-	Emerging prognostic factors in ischemic heart disease
	-	Homocysteine plasma levels in primary biliary cirrhosis (PBC)
Gensini F.	-	Emerging prognostic factors in ischemic heart disease
Gensini F.	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Gensini G. F.	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
	-	TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
	-	Protein Z levels in acute coronary syndromes
Gensini F.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Gensini G. F.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Gent M.	-	Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
	-	A dose–response study of a recombinant human soluble thrombomodulin (ART-123) for prevention of venous thromboembolism after unilateral total hip replacement
	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with nonmetastatic malignancy and venous thromboembolism (VTE)
	-	A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus study
	-	Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
	-	Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
Gentile M.	-	Hemophilia in pediatrics: clinical experience in a single hemophilia center
Gentilomo C.	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
Georgas G.	-	Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
	-	Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
	-	Obesity and coagulation. Is there any correlation?
	-	Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
George P. M.	-	Plasma adiponectin and the metabolic syndrome
George B.	-	Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
George J. N.	-	Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP-HUS): A study of 149 consecutive patients 1996–2002
	-	Analysis of ADAMTS13 activity in consecutive patients with clinically diagnosed thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS)
	-	Long-term outcomes following recovery from thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS) measured by health-related quality-of-life (QOL) assessments
Georgescu D.	-	Use of recombinant activated factor VII (NovoSeven) in patients with liver cirrhosis
Georgopoulos C.	-	High frequency of factor V Leiden and prothrombin G20210A mutations in Greek hemophiliacs
Gerasimenko N. Y.	-	Thrombin accelerates regeneration of mouse peripheral nerve in vivo
Gerber C.	-	High prevalence of aspirin resistance in patients with a history of myocardial infarction
Gerber C. E.	-	Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
	-	Multiplex PCR Nanogen gene chip assay for thrombospondin mutations associated with acute coronary syndromes
	-	Does cyclooxygenase-2 have a role in aspirin-dependent platelet function?
Gerdes V.	-	Effect of hyperhomocysteinemia on coagulation activation and endothelial cell activation
Gerdisch M.	-	A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Gerdsen F.	-	The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
	-	Routine homocysteine monitoring: stabilization of blood samples with fluoride
Gerdsen F.	-	Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia
	-	Risk factors and long-term follow-up of patients with the immune type of heparin induced thrombocytopenia
Gerhardt A.	-	High levels of plasma markers of coagulation factors (I, VIII:C, XI, XII), inflammation, and hyperhomocysteinemia are risk determinants of pre-eclampsia and HELLP syndrome
	-	High levels of plasma markers of coagulation factor VIII:C and von Willebrand factor are independent risk determinants of pregnancy-associated venous thromboembolism
Gerhardt A.	-	Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
	-	Lipid levels and homocysteine are determinants which influence the epinephrine–collagen- and ADP–collagen-closure time
Gerhardt A.	-	Rapid induction of immune tolerance with von Willebrand factor containing factor VIII concentrate in acquired hemophilia A
Gerke V.	-	Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Gerlach R.	-	Malignancy and metastasis is not associated with decreased ADAMTS-13 activity in patients with brain tumors and prostate tumors
Gerlach R.	-	The risk of postoperative hemorrhage after intracranial surgery following early Nadroparin administration – results of a prospective study
	-	Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
	-	The administration of recombinant coagulation factor VIIa (rFVIIa) during neurosurgical procedures
Germagnoli F.	-	Oral anticoagulation telemedicine management system: the MC-SAT project
Germanò G.	-	Antioxidant effect of wine in human: role of polyphenols
	-	Increased platelet superoxide anion production in patients with hypertension: role of AT1 receptors
Germanos-Haddad M.	-	Molecular analysis of factor XI deficiency in 8 Lebanese families: identification of two novel mutations
Germer M.	-	Multicenter study of the DGTI: factor VIII determination of FVIII products with a chromogenic method®
Germeshausen M.	-	Clinical and laboratory findings in a new case of congenital amegakaryocytic thrombocytopenia (CAMT)
Gerotziafas G.	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
Gerotziafas G. T.	-	Measurement of synthetic pentasaccharide fondaparinux (arixtra) anti-Xa activity
Gerotziafas G.	-	Effect of rFVIIa (NovSeven®) on thrombin generation in patients with severe thrombocytopenia
Gerotziafas G. T.	-	Effect of Fondaparinux on clot formation after tissue factor pathway activation. A thromboelastography study
Gerotzuafas G. T.	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
Gerrits W. B. J.	-	Homocysteine lowering by B vitamins and the prevention of secondary deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Gershkovich A. A.	-	Synthesis of arginine-containing peptides and study on their effects upon thrombin
Gershlick A. H.	-	Resistance to fibrinolysis in arterial thrombi: the importance of platelets
Buil A.	-	Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Gervais M.	-	Functional protein S testing does not exclude protein S deficiency
Gessner R.	-	Recombinant PrPP102L stimulates t-PA mediated plasminogen activation 4-fold stronger than recombinant wild-type PrPc
Gewirtz J. E.	-	Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
Ghali W. A.	-	Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
	-	D-dimer for the exclusion of acute deep venous thrombosis and pulmonary embolism: a systematic review
Ghebrehiwet B.	-	Tissue factor pathway inhibitor-2 (TFPI-2) binds the complement and kinin binding protein gC1qR/p33 (gC1qR)
Ghirarduzzi A.	-	Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Ghirarduzzi A.	-	Visceral vein thrombosis: retrospective analysis of 53 cases in five Italian thrombosis
	-	1286 prospective consecutive cases of venous thromboembolic disease at the single venous thromboembolic Unit of Reggio Emilia
Ghirarduzzi A.	-	Clinical quality assessment program for the oral anti-coagulant clinic: preliminary report of a multicentric Italian exercise
	-	Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony)
	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Ghiringhello M. T.	-	Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Ghiselli A.	-	Antioxidant effect of wine in human: role of polyphenols
Ghitescu M.	-	Inter-individual variability in inhibition of platelet activation and aggregation by clopidogrel
Ghosh S. A.	-	Shiga toxin interactions with platelets: differential effects of anti-coagulants and platelet isolation procedures
Ghosh K.	-	Burden of von Willebrand disease in India
	-	Direct detection of factor IX gene deletions in Indian hemphiliacs by multiplex PCR
	-	Diagnosis of neonatal alloimmune thrombocytopenic purpura (NAITP) by genotyping and human platelet antigen frequency in the Indian population
Ghosh K.	-	Glanzmanns thrombasthenia in Indians – how different it is from other ethnic groups
Giacomelli S.	-	Association between fibrinogen levels and fibrinogen G-455 A polymorphism and preclinical atherosclerosis in the general population
Giacomello R.	-	Safety, efficiency and dose saving of continuous infusion modality of protein C concentrate in the management of a protein deficient patient submitted to orthopedic surgical procedure
Giambartolomei S.	-	Factor VIII pharmacokinetics in young boys with hemophilia: novel measures for prophylaxis dosing
	-	Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Giangrande P. L. F.	-	The PFA-100®: a screening tool for platelet dysfunction – the Oxford experience
Giangrande P. L.	-	Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Giannini M.	-	Prophylaxis of deep vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin
Giannini S.	-	Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
	-	The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
	-	Lysosomal beta-N-acetylhexosaminidase is a primer of platelet activation
Giannuzzi P.	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
Giarratano A.	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Gibbins J. M.	-	Evidence for a role of tachykinins in the regulation of human platelet activation
Gibbins J.	-	Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Gibbins J. M.	-	The inhibitory action of quercetin on GPVI-mediated platelet signaling and activation
	-	A role for the thiol isomerase protein P5 in platelet function
Gibbs W.	-	Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Gibbs C.	-	Increased plasma tissue factor predicts adverse outcome in chronic heart failure
Gibson B. E. S.	-	Thromboembolism in childhood: a prospective 2 years study in the United Kingdom (February 2001 – February 2003)
	-	Catheter-related venous thrombosis in children diagnosed by magnetic resonance venography
Gibson R.	-	Using ETP to predict which factor V Leiden heterozygotes will suffer from venous thrombo-embolism
Gibson G.	-	Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Gich I.	-	Self-management of oral anti-coagulation reduces the incidence of complications: preliminary results of the ACOA clinical trial
Giddings J. C.	-	Warfarin-resistant factor VII is a potential risk factor for thromboembolism (TE) after prosthetic heart valve replacement
Giddings J. C.	-	Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats
Giddings J.	-	Population-based study of acquired hemophilia A
Gidrol X.	-	A study of gene expression profiles during megakaryocytopoiesis
Giese C.	-	Anti-coagulant effects of direct thrombin inhibitors: compared for potential use in clinical practice
	-	Impact of direct thrombin inhibitors on actions of vitamin K antagonists on analysis with different coagulation parameters: aPTT and PT for argatroban, hirudin and melagatran
	-	Prophylaxis of recurrent thromboembolism in a patient with a history of heparin-induced thrombocytopenia with thrombosis, anti-lepirudin antibodies after Bjork-Shiley aortic valve implantation using fondaparinux
Giesen P. L. A.	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Giesen P.	-	Effects of platelet agonists and antiplatelet agents on thrombin formation in human plasma
Giesen P. L. A.	-	Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hyper- or hypo-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma
Giesen P.	-	The calibrated Thrombogram: exact monitoring of thrombin generation in clotting platelet rich- and platelet poor plasma
Gigantes S.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Giglioli C.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Gijbels M. J.	-	Tissue-type plasminogen activator (t-PA) gene deletion in apoE3-Leiden mice delays progression of cholesterol-induced atherosclerotic lesion
Gijzen K.	-	The small GTP-binding protein Ral is involved in cAMP-mediated release of VWF from endothelial cells
Gilabert J.	-	Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Gilabert-Estellés J.	-	Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Gilbert G. E.	-	Anticoagulant function of lactadherin correlates with phosphatidyl-L-serine specificity
	-	The mutation Ser2117Leu, in the second hydrophobic spike of the factor V C2 domain, increases phospholipid affinity and specific activity
Gilbert G. E.	-	Calcium ion-independent structure of the factor IX w-loop peptide, FIX(G4–Q11) and its interaction with phosphatidylserine
Gilbert G. E.	-	Limited exposure of phosphatidylserine on stimulated platelets is necessary for procoagulant activity and provides binding sites for lactadherin
Giles A. R.	-	The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
	-	Issues arising in application of the ISTH disseminated intravascular coagulation (DIC) scoring system: the need for modification before prospective validation
Gill J. C.	-	Assay of the von Willebrand factor propeptide in patients with type 1 von Willebrand disease (VWD) and the identification of patients with a S2179F mutation in the D4 region of von Willebrand factor
Gill J. C.	-	Oral factor VIII concentrate for immune tolerance induction: preliminary study of safety in a high responder inhibitor patient
Gill R.	-	Residual platelet function can be detected in patients on antiplatelet therapy using novel Hemoscope reagents and standard Thrombelastograph® (TEG®)
Gille J.	-	P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Gilles J. G. G.	-	Inhibitory effects of human anti-factor VIII monoclonal antibodies and their neutralization by respective anti-idiotypic antibodies using Thrombin Generation Test
Gilles J. G.	-	An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
Gilles J.G.G.	-	Studies of anti-idiotypic polyclonal antibodies developed against antihuman Factor VIII monoclonal antibodies
Gilligan O. M.	-	Type 2M von Willebrand disease: correlation of phenotype with genotype?
Gillis S.	-	Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
Gilmore G.	-	Anti-phospholipid antibodies in ischemic stroke
Gilmour P. S.	-	Procoagulant changes in human macrophages induced by environmental microparticles [PM10]: a possible pathogenetic mechanism in cardiovascular disease
Gils A.	-	Characterization of monoclonal antibodies that inhibit either the activation of proCPU (TAFI) or the activity of CPU (TAFIa)
Gilzinger A.	-	The antiphospholipid syndrome and cerebral manifestations
Ginsberg J. S.	-	Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study
	-	Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Ginsberg M. H.	-	The scaffold function of b3 integrins regulates integrin signaling
Ginsberg J. S.	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Use of different d-dimer levels to exclude venous thromboembolism depending on clinical pretest probability
	-	Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Ginsberg J.	-	Altered regulation of in vivo coagulation in orthopedic patients prior to knee or hip replacement surgery
Ginsburg D.	-	The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function
	-	A sensitized ENU mutagenesis screen for dominant genetic modifiers of thrombosis in the factor V Leiden mouse
	-	MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
	-	ADAMTS13 mutations identified in familial TTP patients result in loss of VWF-cleaving protease activity
Ginsburg J. S.	-	Management of venous thromboembolism during pregnancy
Giordano A.	-	Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Giordano G.	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Giotopoulou S.	-	Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Giotopoulou S.	-	Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
Girardel J. M.	-	Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Girdhar G.	-	Kinetic analysis of mutations associated with a platelet adhesion receptor or its ligand reveals similarities between the genetically distinct bleeding disorders known as PT- and type 2B vWD
Girelli D.	-	Low vitamin B6, markers of inflammation, and coronary artery disease
	-	Modulation of factor V levels in plasma by intragenic polymorphisms
	-	Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
Girisch M.	-	Non-catheter related pulmonary artery thrombosis in a premature
	-	Laborious way to an efficient prophylaxis: Homozygous prothrombin G20210A mutation in a neonate with cardiac diverticulum
Girma J. P.	-	Identification of the bitiscetin-binding site on the von Willebrand factor A3-domain. Comparison to the collagen-binding site
Girma J. P.	-	Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
	-	Identification of seven new candidate mutations of ADAMTS13 gene in four French families related to congenital thrombotic thrombocytopenic purpura
	-	Multicenter comparison of assays for von Willebrand factor-cleaving protease (ADAMTS13) activity
Girma J. P.	-	Stability of 19 mutated recombinant von Willebrand factor to von Willebrand factor-cleaving protease (ADAMTS13)
Girma J.-P.	-	Specific interaction of the proteolytic SPII fragment of von Willebrand factor with fibrin
Girodon-Boulandet E.	-	Fatal intra cerebral hemorrhage due to severe vitamin K deficiency disclosing cystic fibrosis
Girolami B.	-	The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
Girolami A.	-	The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
	-	Increased TAFI-dependent anti-fibrinolytic effect associated with the presence of an anti-FV antibody in a patient with severe thrombophilia
	-	Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
	-	Factor V Gly2112Asp, a C2-domain variant, is associated with severe deficiency and a bleeding tendency
	-	A frequent, apparently silent, polymorphism in prekallikrein (Fletcher factor) gene
	-	Factor VII deficiency associated with severe hemophilia A
	-	The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
	-	The incidence of venous thromboembolism in double-heterozygous carriers of antithrombin, protein C and protein S deficiency and HR2 haplotype
	-	The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
	-	Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
	-	Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
	-	Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
	-	Interaction of factor VIII and von Willebrand factor investigated in a large cohort of von Willebrand disease patients: evaluation of the type 2N variant prevalence
	-	The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
	-	Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
	-	Anti-prothrombin antibodies in patients with recurrent venous thromboembolism
	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
	-	Atherosclerosis as a potential risk factor of venous thrombosis
	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Girolami B.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Girolami A.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Girolami A.	-	Relapsing, recurrent and residual deep vein thrombosis
Girolami A.	-	Dental implants in anti-coagulated out-patients
Girtovitis F.	-	Sticky platelet syndrome
	-	Synthetic tripeptides with specific inhibitory action against Gp-Ib glycoprotein
	-	Congenital defect of inferior vena cava and thrombophilia Leiden
	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory follow-up
	-	Thrombophilic tendency in patients with chronic renal disease submitted to regular dialysis
	-	Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
	-	Treatment of DIC: the role of PC
	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory monitoring
Gissel M. T.	-	Systemic enzymatic activity in blood?
Giudicelli Y.	-	Prevalence of methylenetetrahydrofolatereductase (MTHFR) gene polymorphism (C677T) in the Moroccan population
Giuello A.	-	Emerging prognostic factors in ischemic heart disease
	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Giumarães D. A. M.	-	Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Giusti B.	-	High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
Giusti B.	-	Optimization of human 14 000 oligonucleotide-microarrays and study design for the evaluation of gene expression profiling in cardiovascular diseases
Giusti B.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Giustolisi R.	-	The platelet glycoprotein IIb/IIIa receptor antagonist c7E3Fab inhibits the coagualation activation in patients undergoing to percutaneous transluminal coronary angioplasty (PCTA)
	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Glader B.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Glambedaki M.	-	Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Glampedaki M.	-	Left adrenal hemorrhage with intravascular coagulation- case report
Glas A. S.	-	Physicians' interpretation of ventilation-perfusion lung scans
Glase C.	-	Thrombosis prophylaxis following total hip replacement
	-	Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines
GLATIT STUDY GROUP‡	-	Modulation of clinical phenotype of Glanzmann's Thrombasthenia by the C807T alpha2 gene polymorphism
Glenn J. R.	-	The mechanism of platelet aggregation in whole blood in response to adenosine triphosphate: involvement of neutrophil ecto-ATPase activity and adenosine
Glenscheck C.	-	Molecular genetic analysis of gene variants in the 5' flanking region of the FVII gene: Identification of a novel mutation in a German family
Gloanec P.	-	Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
Gloe T.	-	A cytochrome P450 2C8/9-derived EDHF inhibits platelet adhesion to endothelial cells in vitro
Glomstein A.	-	Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Glory Investigators	-	Screening for asymptomatic deep vein thrombosis after major orthopedic surgery: findings of the Global Orthopaedic Registry (GLORY)
Glueck C. J.	-	Legg-Perthe's disease and thrombophilia: a causal association?
Glusa E.	-	Thrombin-mediated Ca2+ responses in chick embryo cardiomyocytes and cardiofibroblasts
Gluszko P.	-	Suppression of thrombin generation and fibrinolysis in patients with rheumatoid arthritis treated with anti-TNFa monoclonal antibody (Infliximab)
Gluück B.	-	A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Glynn R.	-	Long-term, low-intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial
Gnatenko D.	-	Human blood platelets: RNA transcript profiling using microarray and serial analysis of gene expression
Gnezdilova N.	-	Advantage of the ‘Quick’ thrombolysis by streptokinase (SK)
Godoi L. C.	-	Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Godoi L. C.	-	Markers of hypercoagulability in Brazilian patients with DVT undergoing oral anti-coagulation therapy
Goecke T.	-	High levels of plasma markers of coagulation factors (I, VIII:C, XI, XII), inflammation, and hyperhomocysteinemia are risk determinants of pre-eclampsia and HELLP syndrome
Goedje O.	-	Comparison of two methods to assess platelet activation during and after CABG
Goedjs O.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Goel M.	-	Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow by activating fibrinogen-adherent platelets
	-	Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma
Goff S.	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Golanski J.	-	Time-dependent restoration of effective inhibition of blood platelet function after coronary artery by-pass grafting
Golanski R.	-	Time-dependent restoration of effective inhibition of blood platelet function after coronary artery by-pass grafting
Goldberg M. M.	-	Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement
Goldenberg N.	-	Lipoprotein A contributes to genetic risk for Venous Thrombosis and Arterial Stroke in U.S. Children
	-	Activated protein C resistance in cancer-associated venous thromboembolism
Goldhaber S.	-	Foundations of clinical practice - Bridging the gap between knowledge and practice
Goldhaber S.	-	Long-term, low-intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial
Goldhaber S. Z.	-	A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely Ill medical patients: the PREVENT medical thromboprophylaxis study
Goldhaber S. Z.	-	Acute deep vein thrombosis: A prospective registry of 5451 patients
Goldman M.	-	Phenotype of T cells in human abdominal aortic aneurysm
Goldschmidt N.	-	Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
Golmard J. L.	-	Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
Goltsova K. V.	-	Anti-hemostasis stimulated by the medicinal leech application as a result of mast cells activation by the leech saliva
Golubeva M.	-	Clopidogrel and ticlopidine induced experimental hemorrhagia and possibility it's correction with help vasopressin analogue DGAVP
Golubeva M.	-	The effect of thyrotropine releasing hormone on blood coagulation
Golubykh V.	-	Combined anti-thrombotic protection of vascular wall with bienzyme superoxide dismutase–chondroitin sulphate–catalase conjugate in vivo
Gomes N.	-	Platelet aggregates modulate the adhesion of breast adenocarcinoma cells (MDA-MB-231) to endothelial cells and their matrix in whole blood and under flow conditions
Gomez R. M.	-	Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Gomez R.	-	Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Gomez K.	-	Two novel mutations in severe factor VII deficiency
Gomez Garcia E. B.	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
Gomez-Garcia E. B.	-	Genetic variability of von Willebrand factor and coronary heart disease: the Rotterdam Study
	-	Association between genetic variability of von Willebrand factor and peripheral atherosclerosis: the Rotterdam Study
Gomide F.	-	Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Gomperts E.	-	Development of economic and outcomes model of hemophilia treatment in Latin America and South-east Asia
Gonçalves L.	-	Effects of cardiopulmonary bypass on platelet activation markers
Goncalves I.	-	Integrin aIIbb3 outside-in calcium signals sustain platelet–fibrinogen interactions under flow
Gonchar V. A.	-	Xenogenic immunoglobulins can be used in treatment coagulation disorders
Gonzalez G.	-	Retrospective analysis of heritable thrombophilia in 90 children with Legg-Perthes disease
Gonzalez N.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
González N.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Gonzalez R.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
González R.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Gonzalez-Boullosa R.	-	A new candidate mutation (C1272S) in type 2 A von Willebrand disease (VWD) affecting the disulfide loop responsible for the interaction of von Willebrand factor (VWF) with platelet glycoprotein Ib-IX
González-Conejero R.	-	Conformational basis of homozygous heparin cofactor II deficiency confirms critical role of P17 glutamate in serpins
	-	Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
	-	Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
	-	Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
González-Conejero R.	-	Genetic variations of the extra-large stimulatory G protein a-subunit and risk of thrombotic and hemorrhagic disorders
González-Conejero R.	-	Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
Gonzalez-Fajardo J.A.	-	Management and outcome of patients with venous thromboembolism: a prospective registry including over 5000 consecutive patients
Gonzalez-Porras J. R.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Goodall A. H.	-	The use of phospholipid-dependent clotting assays to characterize the cell-surface procoagulant activities of T-lymphoblastoid cell lines
	-	Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
	-	Different classes of contrast media affect the formation and subsequent lysis of thrombi formed in vitro in whole blood under conditions of flow
	-	A thrombomodulin (TM) gene promoter variant (TM-33G > A) in type 2 diabetes
Goodall A.	-	Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Goodall A. H.	-	Influence of flow on inhibition of platelet dependent thrombin generation by an anti-GPIIb/IIIa antibody
	-	Resistance to fibrinolysis in arterial thrombi: the importance of platelets
	-	Regulation of GPVI-mediated platelet procoagulant response and degranulation
	-	The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
	-	The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
	-	Soluble endothelial cell markers (sTM, sEPCR and sVWF) in type 2 diabetes
	-	Prevention of thromboemboli by enhancing fibrinolysis: a possible therapeutic mechanism of action for Dextran-40
Goodeve A. C.	-	A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
	-	A new von Willebrand factor (VWF) online mutation and polymorphism database created on behalf of the ISTH VWF scientific and standardization committee (http://www.sheffield.ac.uk/vwf)
	-	Fluorescent conformation sensitive gel electrophoresis (F-CSGE) analysis of the VWF gene: A high throughput, sensitive mutation detection system
	-	A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
Goodeve A.	-	Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
Goodeve A. C.	-	Characterization of mutations in a cohort of type 2 von Willebrand disease patients
Goodeve A.	-	Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
	-	Splice site mutations of the von Willebrand factor gene in patients previously diagnosed with von Willebrand disease type 1
Goodeve A. C.	-	In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
	-	Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
Goodeve A.	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
Goodeve A.	-	Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Goodeve A.	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
Goodeve A. C.	-	Profile of mutations in a UK hemophilia A patient population
Goodman S. L.	-	Structure of the alphaVbeta 3 receptor
Goodnough G.	-	Bleeding due to platelet disorders - and treatment: Experiences with rFVlla in thrombocytopenic patients
Goodwin C. A.	-	Evidence supporting a functional role for the metal binding site observed within the protease domain of Factor IXa
Goodwin C.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Goodyear M.	-	A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
Gooren L. J. G.	-	Venous thrombosis and APC resistance during hormone treatment in male-to-female transsexuals
Goormastic M.	-	High prevalence of aspirin resistance in patients with a history of myocardial infarction
Gordge M.	-	Platelet glycoprotein Iba VNTR polymorphisms: association with thromboembolic diseases
Gori A. M.	-	Optimization of human 14 000 oligonucleotide-microarrays and study design for the evaluation of gene expression profiling in cardiovascular diseases
	-	Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Gori A.M.	-	Evaluation of the fibrinolytic capacity before and after venous occlusion performed by serum d-dimer test after standardized coagulation
Gori A.	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Gori A.M.	-	Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
Gorina E.	-	Evaluation of IgG formation to trace mammalian proteins in hemophilia patients treated with a recombinant therapeutic protein preparation
Gorina E.	-	Stability of rFVIII-FS after continuous infusion using a mini-pump infusion device
	-	Health-related quality of life in adults with hemophilia: the patient perspective
Gorkun O. V.	-	High resolution crystal structures of two variant fibrinogens suggest ‘B:b’ interactions are critical to normal polymerization
Gornall A.	-	Changes in thromboelastography in low-risk women in the puerperium
Gorodestskiy V. M.	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Gorodetskiy V. M.	-	Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
Gorodetsky V. M.	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Gorodetsky V.	-	Use of recombinant activated factor VII (rFVIIa) for management of postoperative bleeding in patients with idiopathic thrombocytopenic purpura (ITP)
Gorter G.	-	Platelet sensitization is mediated by Apolipoprotein E Receptor 2
	-	PECAM-1 inhibits LDL-signaling in platelets
	-	The effect of oxidized low-density lipoprotein on the activation of platelets
Gortney J.	-	Improving bridge-out therapy with low-molecular-weight heparin in an urban, inner city medical center
Gortzolidis G.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Gosavi S.	-	A new method for identification of false-negative testing for lupus anticoagulant due to contamination of test plasma by platelet-derived micropatricles
Goshen H.	-	Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications
Gosk-Bierska I.	-	Cerebral venous sinus thrombosis. The spectrum of risk associated with this unique thrombotic disorder
	-	Risk of recurrence of cerebral venous and sinus thrombosis, influence of treatment
Gosk-Bireska I.	-	Plasmin-alpha2–anti-plasmin complex in diabetic and non diabetic patients with peripheral arterial occlusive disease
Gosselaar C.	-	Evaluation of a bed-side device to assess the APTT for heparin monitoring in infants
Gosselin R. C.	-	Protein C levels in critically ill ICU patients: differences seen between patients with and without sepsis
Gosselin R. C.	-	Effect of short-term, low-fat vegetarian diet and walking program on coagulation
Gotanco G.	-	Determination of the interassay variability of d-Dimer measurements near the critical cut-off point used for the exclusion of venous thromboembolism, on the MDA-180 coagulation analyzer
Goto S.	-	Platelet GP VI can be new anti-platelet target for prevention of acute coronary syndrome
Goto S.	-	Imaging and characterization of the procoagulant activity appeared on the surface of platelet thrombi formed on the collagen surface under blood flow conditions
Goto S.	-	Dissolving effects of anti-GP IIb/IIIa agents on platelet thrombi formed on the collagen surface under blood flow conditions
Goto S.	-	Real-time visualization of platelet shape changes occurring in response to their adhesion on immobilized type I collagen or von willebrand factor under controlled blood flow conditions
Götting C.	-	Quantification of tissue factor pathway inhibitor (TFPI) in human seminal plasma and in human ovarian follicular fluid
	-	Expression of wild type tissue factor pathway inhibitor (TFPI) and the first natural TFPI mutant ([P151L]) in insect and mammalian cells
Gottlieb S. O.	-	Platelet inhibition by valsartan and valeryl 4-hydroxy valsartan: a possible missing link to explain benefits of angiotensin II receptor blockers in patients after acute vascular events
Goubran F.	-	Tissue factor and tissue factor pathway-inhibitor in chronic hepatitis C patients
Goubran F.	-	Thrombin activatable fibrinolysis inhibitor in thrombophilic patients with activated protein C resistance
Goudemand J.	-	Evaluation of automated measurement of ristocetin cofactor activity of von Willebrand factor on STA-R® in von willebrand disease: study in 154 patients
	-	Analytical validation of the automated measurement on STA-R of the ristocetin cofactor activity (VWF:RCo) of von Willebrand factor
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
	-	Effect of type of treatment (recombinant vs. plasmatic) on FVIII inhibitor incidence according to known risk cofactors in previously untreated severe hemophilia A patients (Pups)
	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
	-	Interest of diluted Russel viper venom time (dRVVT) in determining “pathogenic” lupus anticoagulants
Goudemand J.	-	Treatment of patients with inhibitors with FEIBA: the French experience from 1995 to 1999
Goudemand J.	-	Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Gouédard C.	-	Effect of hyperhomocysteinemia on paraoxonase activity
Gouin I.	-	Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
Gouin-Thibault I.	-	Heparin releasable TFPI Is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days
Gould W. R.	-	Inhibition of human prothrombinase by PD0313052 reveals advantages of active site-directed factor Xa inhibition
Gould W. R.	-	The Gas6 receptors Axl, Sky, and Mer function to enhance human platelet degranulation and aggregation
Gourdier A. L.	-	Diagnosing pulmonary embolism with clinical assessment, d-dimer, venous ultrasound and helical computed tomography: a multicenter management study
Gourdy P.	-	The protective effect of estradiol is dependent on immune system for spontaneous atherosclerosis but not for injury-induced atherosclerosis
Govers J.	-	IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
Govers-Riemslag J. W. P.	-	Enhanced thrombin generation and mild bleeding tendency in a severely FVII-deficient patient carrying FV Leiden
Goyal P.	-	Analysis of the Rho-kinase/LIM-kinase/cofilin signaling pathway in activated platelets
Goycoolea M.	-	Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
	-	Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Graafsma S.	-	Effects of genes and environmental factors on homocysteine level
Grabensee B.	-	Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Grabowski M.	-	Activity of endogenous fibrinolytic system induced by exercise ECG test in patients with previous positive ECG-exercise test but without essential atherosclerotic changes in coronaries during angiography
Grabowski E. F.	-	Globotriasylceramide (Gb3) and blood-borne tissue factor (TF) colocalize with platelets during platelet adhesion/aggregation onto a collagen-coated surface exposed to flowing blood
Grabowski E. F.	-	Shiga toxin with antecedent TNF-a induces enhanced tissue factor activity on human glomerular, but not on umbilical vein, endothelial cells
Graeber J.	-	Construction and characterization of a new recombinant plasminogen activator composed of an antifibrin single-chain antibody and a low molecular weight form single-chain urokinase
Graff J.	-	Effects of argatroban alone or in combination with phenprocoumon or acenocoumarol on aPTT and ecarin clotting time
Graham D.	-	Low-molecular-weight heparin dose requirements are age-related through childhood
Graham A.	-	The phagocytic capacity of human endothelial cells in culture for apoptotic endothelial cells is inhibited by IgG from patients with anti-phospholipid antibodies
Graham G. J.	-	A role for the thiol isomerase protein P5 in platelet function
Graham F.	-	The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy
Graham G.	-	Evidence for a role of tachykinins in the regulation of human platelet activation
Graham F.	-	Treatment of severe canine hemophilia A by helper-dependent adenoviral-mediated gene therapy
Grailly S.	-	An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
	-	Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
Grambach K.	-	Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Grancha S.	-	Limited ability of nonactivated partial thromboplastin time to monitor clotting factors activation in high purity/high potency Factor IX concentrates
Grandini A.	-	Modulation of factor V levels in plasma by intragenic polymorphisms
Grandone E.	-	Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
Grandone E.	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Grandone E.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
	-	The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
	-	FV plasma levels and the activated protein C resistance phenotype are modulated by the FV gene Asp79His polymorphism in presence of the FV Leiden mutation
Grandone E.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
Grandone E.	-	Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
Granier C.	-	Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
	-	Studies of anti-idiotypic polyclonal antibodies developed against antihuman Factor VIII monoclonal antibodies
Grant P.	-	Genetics of atherothrombotic disorders: a clinical perspective
Grant P. J.	-	Plasma leptin is associated with hemostatic cardiovascular risk factors
	-	The influence of metformin on markers of inflammation in subjects with type 2 diabetes mellitus: evidence to support the common soil hypothesis
	-	P-selectin polymorphisms: their relationship to soluble P-selectin levels and cardiovascular risk
	-	Complement C3 and its relationship to features of the insulin resistance syndrome and cardiovascular disease
	-	b3 integrin haplotype influences gene regulation
Grant M. A.	-	Calcium ion-independent structure of the factor IX w-loop peptide, FIX(G4–Q11) and its interaction with phosphatidylserine
Grant P. J.	-	The effect of factor XIII Val34Leu on clot structure is fibrinogen dependent: evidence for a mechanism for cardioprotection of the Leu allele at high fibrinogen levels
	-	Genetics of fibrin clot structure and interactions with factor XIII: a twin study
	-	Bb448 Lys/Lys variant alters coronary risk by an effect on fibrin structure/function due to conformational changes in fibrinogen
	-	Cross-linking of fibrin by factor XIII and its effect on fibrin structure/function
	-	Fibrinogen gamma chain splice variant (g') alters fibrin structure and function
	-	Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation: competition for cofactor sites on thrombin determines its fate
	-	The relationship between nonenzymatic glycation and fibrin structure/function: a mechanism for increased vascular risk associated with hyperglycemia
	-	Increased coagulation factor XIII B subunit antigen and factor XIII biotin activity is associated with family history of stroke in South Asians
	-	Increased factor XIII B and decreased factor XIII A subunit antigen levels in insulin resistant South Asian patients with ischaemic stroke
Granzotto M.	-	Factor VII deficiency associated with severe hemophilia A
	-	A frequent, apparently silent, polymorphism in prekallikrein (Fletcher factor) gene
	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
Granzow K.	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Grassman E. D.	-	Platelet and inflammatory changes induced by angioplasty and brachytherapy
Gratacap M. P.	-	Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
Gratacap M. P.	-	Lipid rafts in platelet activation processes
Gratkowski H.	-	Activation of the platelet integrin aIIbb3 by thermodynamic modulation of transmembrane helix associations
Gratsiansky N. A.	-	Changes of hemostatic parameters in patients with non-ST elevation acute coronary syndrome treated with atorvastatin or pravastatin (randomized comparative study)
	-	Clopidogrel in non-ST-elevation acute coronary syndrome: effect on parameters of fibrinolysis and blood coagulation
Gratwohl A.	-	VCAM-1/VLA-4 up-regulation as a perpetuation loop in patients with chronic graft vs. host disease?
Grau A. J.	-	Platelet function under aspirin, clopidogrel and both after ischemic stroke. A case-crossover study
Graw J.	-	Epitopes of factor VIII inhibitors analyzed by peptide-arrays
	-	Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
Gray E.	-	The modulation of lipopolysaccharide induced gene expression and protein production by anti-thrombin
	-	Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
	-	Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
	-	The use of phospholipid-dependent clotting assays to characterize the cell-surface procoagulant activities of T-lymphoblastoid cell lines
	-	Influence of flow on inhibition of platelet dependent thrombin generation by an anti-GPIIb/IIIa antibody
	-	Effect of antithrombin on lipopolysaccharide stimulated gene expression by human umbilical vein endothelial cells
Gray J.	-	Quantitative transcript profiling and novel gene identification of vascular endothelial cell subtypes by serial analysis of gene expression (SAGE)
Gray E.	-	International collaborative study on analyzing methods for determination of direct thrombin inhibitors
Gray E.	-	A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
	-	The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
Graziano M.	-	Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Greaves M.	-	The CAVA study: a double-blind randomized controlled trial of clopidogrel and aspirin vs. aspirin alone in patients with intermittent claudication undergoing peripheral percutaneous transluminal angioplasty
Greaves M.	-	Antiphospholipid syndrome: clinical diversity and anti-thrombotic therapy
Greaves M.	-	Evidence of transient endothelial activation in patients in sinus rhythm after electrical cardioversion of persistent atrial fibrillation
	-	Thrombolytic properties of normal human neutrophils
	-	Plasminogen activators: a feature of normal myeloid differentiation or leukemic transformation?
	-	The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
	-	The phagocytic capacity of human endothelial cells in culture for apoptotic endothelial cells is inhibited by IgG from patients with anti-phospholipid antibodies
	-	Screening for thrombophilia: an economic assessment
	-	Procoagulant changes in human macrophages induced by environmental microparticles [PM10]: a possible pathogenetic mechanism in cardiovascular disease
	-	Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
	-	Routine coagulation screening to predict surgical bleeding is frequently misleading, of no significant clinical value and should be abandoned: results of a systematic review
	-	Enhanced in vivo platelet activation in patients with peripheral arterial disease, and differences between intermittent claudication and critical limb ischemia
Green F.R.	-	Haplotype and tissue-specific control of interleukin-6 expression and the implications in athero-thrombotic disease
Green E. S.	-	Management of pulmonary embolism: Can we consider outpatient treatment?
Green F. R.	-	Variation of GPVI levels in platelets: relationship to platelet function at high shear
Green D.	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Greenfield R.	-	Determination of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, hemophilia B and von Willebrand disease
Greenidge P.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Greenland S.	-	A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Greenway A.	-	Anti-coagulation clinics for children achieve improved warfarin management
Greer I.	-	Management of venous thromboembolism during pregnancy
Greer I. A.	-	Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population
Greer I.	-	The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
Greer I. A.	-	The effect of low and high dose aspirin on the expression of monocyte tissue factor
Greer I.	-	Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
Greer I.A.	-	The effect of ABO and Secretor genotypes on thrombin generation
Greer I.	-	Screening for thrombophilia: an economic assessment
Greer I. A.	-	The G>T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia
Gregorini L.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Gregory M.	-	Role of two populations of thrombocytes in arterial thrombosis in zebrafish
Greinacher A.	-	Expression and function of platelet glycoproteins in newborns and adults
	-	New data on the treatment of HIT (meta-analysis of three prospective studies of lepiruden in the prevention of thrombosis in patients with heparin-induced thrombocytopenia)
	-	The impact of GPIIb-IIIa and GPIa-IIa polymorphisms on the adhesion of platelets to collagen and fibrinogen in a microtiter-plate adhesion system under static and dynamic conditions
	-	Benefit and risk of heparin addition in maintaining peripheral venous catheters in neonates – a prospective, double-blind, placebo-controlled trial
Greinacher A.	-	Anaphylactic reactions associated with lepirudin in patients with heparin-induced thrombocytopenia (HIT)
Greinacher A.	-	HIT type II: diagnostic approches and current treatment concepts based on the pathogenesis of HIT - the European experience
	-	Cross-reactivity of anti-lepirudin antibodies from patients with heparin-induced thrombocytopenia with bivalirudin
Grekas D.	-	Thrombophilic tendency in patients with chronic renal disease submitted to regular dialysis
Gremigni P.	-	Emotional impact of testing for inherited thrombophilia
Grenard A. S.	-	Oral anti-coagulation in elderly patients in clinical practice: 187 patients
Gresele P.	-	Interaction between thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anti-coagulant treatment
	-	Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
	-	Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants: a case-control study
	-	Management of oral anticoagulant therapy with Thrombotest® using a whole blood testing device (Thrombotrack®) in comparison to routine laboratory PT
	-	Lysosomal beta-N-acetylhexosaminidase is a primer of platelet activation
	-	LPS induced MMPs release in mice: role of platelets and inhibition by NCX4016 (nitroaspirin)
	-	Platelet-derived nitric oxide (NO) is suppressed by hyperhomocysteinemia: a possible prothrombotic effect
	-	A comparison between routine plasma INRs and fingerstick whole blood INRs determinations, using three portable self-testing devices (Coagucheck®, Pro-Time®, Gem-PLC®) and a near-patient whole blood device (Thrombotrack®)
	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Grez M.	-	Developing hematopoietic stem cells as targets for gene therapy of hemophilia A
	-	Intracellular trafficking of native, full-length, and B-domain-deleted coagulation factor VIII (FVIII) in mammalian cells
Griesshammer M.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
	-	Comparison of two methods to assess platelet activation during and after CABG
	-	Successful treatment with rituximab in a case of relapsed acquired hemophilia
Griffin J.	-	Neutral and charged lipids in factor Va inactivation
Griffin J. H.	-	Synergy between deficiencies of plasma glucosylceramide and deficiency of activated protein C for venous thromboembolism
	-	Amino acid sequences in factor Xa that bind prothrombin and factor Va
	-	Sphingosine and certain sphingolipid analogs are potent anticoagulants as prothrombinase inhibitors
	-	Oral contraceptives decrease the sensitivity of plasma for the anticoagulant activity of activated protein C (APC) by decreasing plasma glucosylceramide (GlcCer) level
	-	A novel engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa
	-	Recombinant murine activated protein C is neuroprotective in a murine ischemic stroke model
Griffin J. H.	-	In vivo activated protein C (APC) neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Griffin J. H.	-	Amino acid sequences in human prothrombin that interact with factor Xa and factor Va
	-	Characterization of the anti-apoptotic effect of activated protein C
	-	Characterization of a thrombomodulin binding site on protein C and its distinction from an activated protein C binding site for factor Va
	-	Activated protein C anticoagulant activity mediated by phospholipid vesicles is enhanced by cholesterol and sphingomyelin
	-	Platelet factor 4 up-regulates protein C activation relative to TAFI activation
Griffin B. D.	-	Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
Griffin J. H.	-	Protein S confers neuronal protection during ischemic/hypoxic injury in mice
Griffin J. J.	-	Activated protein C (APC) blocks p53-mediated apoptosis in ischemic human brain endothelium through endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Griffith L.	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
Grigorjeva M.	-	Clopidogrel and ticlopidine induced experimental hemorrhagia and possibility it's correction with help vasopressin analogue DGAVP
Grigorjeva M.	-	The effect of thyrotropine releasing hormone on blood coagulation
Grilli A.	-	Inhibition of 3-Hydroxy-3-methylglutaryl coenzyme-A reductase attenuates expression of inducible nitric oxide synthase in cardiac myoblasts – Possible link to direct myocardial protection during ischemia-reperfusion
Grillowitzer M.	-	ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
Grimaux M.	-	A modified ELISA procedure for platelet factor 4 with decreased heparin sensitivity
Grinberg M.	-	Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
Gringel E.	-	Comparative evaluation of a new automated latex agglutination d-dimer assay for exclusion of deep vein thrombosis
Gringeri A.	-	Arterio-venous fistula as permanent access for home treatment in children with hemophilia: long-term safety and feasibility
	-	The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Gringeri A.	-	Conjoint analysis: a new technique to quantify individual's preferences, to develop outcome measures and to determine optimal treatment patterns in hemophilia
Grino M.	-	Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
Gris J. C.	-	Anti-protein Z antibodies in women with abnormal pregnancies
	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
Gritsch H.	-	Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
Gritsenko P. G.	-	Utilization of monoclonal antibodies for the quantification of molecular markers of hemostasis
Gritsenko P.	-	New polymerization sites in the central and peripheral domains of human fibrin molecule
Groebke K.	-	The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Gronda E.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Gröner A.	-	Limiting the parvovirus B19 load in manufacturing pools results in final containers of plasma derivatives nonreactive for parvovirus B19 genome
	-	Prions are removed from equipment used in the production of plasma derivatives by standard cleaning procedures
	-	Virus validation studies utilizing model viruses are relevant for west Nile virus
Groot A. P.	-	Blood-borne tissue factor aggravates the outcome of endotoxemia
	-	Differential effects of tissue factor haploinsufficiency during LPS stimulation
Groot F.	-	Plasminogen activator inhibitor PAI-1 as a regulator of urokinase in angiogenesis
Gross P. L.	-	Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
	-	Time-dependent distribution of P-selectin in an arterial thrombus in vivo defines leukocyte rolling during thrombus formation
Grossi A.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Grossjohann B.	-	The impact of GPIIb-IIIa and GPIa-IIa polymorphisms on the adhesion of platelets to collagen and fibrinogen in a microtiter-plate adhesion system under static and dynamic conditions
GroßJohann B.	-	Expression and function of platelet glycoproteins in newborns and adults
Grossman E.	-	Safety and tolerability of argatroban anticoagulation in patients with end-stage renal disease undergoing hemodialysis: a prospective study
Grosso S. H.	-	Platelet von Willebrand factor antigen (VWF:Ag-i) in patients with mucocutaneous bleeding tendency and normal von Willebrand factor (VWF) plasma levels
Grosso S. H.	-	Effects of factor VIII (fVIII) levels and activated partial thromboplastin time (aPTT) in activated protein C resistance (APC-R) ratio using two different methods
Grosso L. E.	-	A new method for identification of false-negative testing for lupus anticoagulant due to contamination of test plasma by platelet-derived micropatricles
Grosso S. H.	-	Influence of factor VIII (fVIII) levels in patients treated with DDAVP on the activated protein C resistance (APCR)
Grove E.	-	The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
Groves B.	-	Unexpected pattern of hypercoagulable states in patients with patent foramen ovale (PFO) or atrial septal defect (ASD) and neurological events
Gruber A.	-	Factor XI dependency of tissue factor-initiated thrombus propagation
Gruber A.	-	Selection and characterization of a novel factor XI inhibiting peptide by using phage display technology
	-	Dose-dependent inhibition of thrombosis by melagatran in a nonhuman primate model
Gruber F.	-	Oxidized phospholipids inhibit action of endotoxin in vitro and in vivo
Gruber A.	-	Experience of using FEIBA™ to attenuate the effects of anticoagulation on inhibition of thrombogenesis in primates
Gruel Y.	-	Frequency of platelet glycoproteins alpha2807T and GPIbalpha Kozak polymorphisms in central retinal vein occlusion
Gruel Y.	-	Changes in the platelet count (PC) after cardiopulmonary bypass (CPB) can efficiently predict the development of pathogenic heparin- dependent antibodies (Abs)
Gruel Y.	-	G20210A prothrombin gene mutation appears as the most important inherited prothrombotic risk factor in ‘idiopathic’ portal vein thrombosis
	-	Quantitative evaluation of TFPI-2 and MMP-9 expression in nonsmall cell lung cancer
	-	Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells
	-	Demonstration of a tissue factor pathway inhibitor-2 (TFPI-2) mRNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas
	-	Inherited risk factors are different in pregnant and nonpregnant women with venous thromboembolism
Gruener S.	-	Normal arterial thrombus formation in integrin a2-deficient mice
Gruener S.	-	Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
Gruenewald M.	-	Comparison of two methods to assess platelet activation during and after CABG
Gruenewald A.	-	Comparison of two methods to assess platelet activation during and after CABG
	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Gruenewald M.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Grundmann C.	-	The thrombogenic agent in prothrombin complex concentrates (PCC): Identification of elevated levels of prothrombin as the major cause
Grundt H.	-	Tissue factor is a major determinant of thrombogenicity following an acute myocardial infarction
	-	Changes in homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids (PUFAs) administered after an acute myocardial infarction
Grunebaum L.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Grünewald M.	-	Successful treatment with rituximab in a case of relapsed acquired hemophilia
Gruppo R.	-	Continuing clinical evaluation of an advanced category recombinant FVIII, antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in previously treated patients (PTPs)
Gruppo R. A.	-	Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis – a meta-analysis
Gruppo R. A.	-	Legg-Perthe's disease and thrombophilia: a causal association?
	-	A case of compound type 2N/type 1 von Willebrand disease linked to a novel von Willebrand factor exon 18 mutation A2311G encoding for Met 771 val
Guadagni F.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Gualandro S. F. M.	-	Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
Gualdoni A.	-	A case of multiorgan atherosclerotic disease in patient affected by hyperhomocystinemia with multiple heterozygous mutations
Guarnaccia G.	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Guazzaloca G.	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
	-	Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
	-	D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
	-	Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
Gudmumdsdottir B. R.	-	Platelet dysfunction in Icelandic teenagers. The bleeding assessment in teenagers (BAT) study
Gudmundsdottier A.	-	Bleeding symptoms, von Willebrand factor (vWF) and von Willebrand's disease in Icelandic teenagers. The Bleeding Assessment in Teenagers (BAT) Study
Guegen R.	-	Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
Gueguen R.	-	Lack of correlation between HPA1 polymorphism and ADP induced platelet activation: study of a large cohort of normal subjects
	-	There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
	-	Influence of R353Q factor VII gene polymorphism on the plasma FVII levels in a French native population (The Fitenat Study)
	-	Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the Fitenat study)
	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
Guercini F.	-	Low molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anti-coagulants
Guerin V.	-	Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Guerrero J. A.	-	Genetic variations of the extra-large stimulatory G protein a-subunit and risk of thrombotic and hemorrhagic disorders
Guerret S.	-	Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
Guerrini U.	-	Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
	-	Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats
Guessous F.	-	Release of chemokines by monocytes and endothelial cells upon exposure to Shiga toxin and LPS: potential roles in platelet activation
Guevara L.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Gueyffier F.	-	A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Gugeyedova O. A.	-	The principles of therapy of hemorrhagic vasculitis at children
Guglielmini G.	-	Platelet-derived nitric oxide (NO) is suppressed by hyperhomocysteinemia: a possible prothrombotic effect
Guicheteau M.	-	Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
Guiheneuf C.	-	Clinical and laboratory findings in a new case of congenital amegakaryocytic thrombocytopenia (CAMT)
Guillaumon A. T.	-	Evaluation of skeletal muscle perfusion in a hindlimb ischemia model using 99 mTc-sestamibi scintigraphy
Guillebaud J.	-	Activated protein C resistance (APCR) and combined oral contraceptives: acquired APCR is more pronounced in women receiving desogestrel containing COCs than those containing levonorgestrel and is associated with low protein S levels
Guillet B.	-	Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Guilliatt A.	-	Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Guilliatt A. M.	-	Two candidate type 2 M von Willebrand disease mutations in two unrelated families with unusual phenotypes
	-	Evaluation of a protein truncation test (PTT) for mutation detection in von Willebrand disease
Guilliatt A. M.	-	Identification of six novel mutations in families with type 3 von Willebrand disease
Guilliatt A. M.	-	Inherited and de novo von Willebrand disease ‘Vicenza’ in UK families with the R1205H mutation
	-	A common mutation 4247T ® A (I1416N) causing type 2M von Willebrand disease in patients from three unrelated families previously diagnosed as severe type 1 VWD
Guillin M. C.	-	Functional characterization of a naturally occurring homozygous Gly25Ser mutation in thrombin B chain
	-	Specific phosphatidylserine exposure and microparticules shedding induced by a synthetic peptide
Guillin M.C.	-	Thrombospondin triggers P-selectin expression and phosphatidyl serine exposure on platelets
Guillin M. C.	-	Glycoprotein Ib-mediated platelet activation: a signaling pathway evoked by thrombin
	-	Influence of R353Q factor VII gene polymorphism on the plasma FVII levels in a French native population (The Fitenat Study)
	-	a2b1 density and a2 polymorphisms in coronary artery disease
	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
	-	Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
Guillin M.C.	-	Thrombin regulates the expression of its cellular inhibitor protease nexin-1 in smooth muscle cells
Guillot K.	-	Clinical experience with optional cava filters
Guimarães A. H. C.	-	A comparison of assay methods for thrombin activatable fibrinolysis inhibitor (TAFI)
Gulbas Z.	-	Evidence for a functional role of 5-hydroxytryptamine-2 A receptor gene (HTR2A) polymorphism (T102C) in human platelet aggregation
Gullestad L.	-	Interleukin-7-mediated inflammation in unstable angina – possible role of chemokines and platelets
Gumulec J.	-	Incidence of hyperhomocysteinemia in patients with symptoms of thrombophilia
Gunewardena K.A.	-	A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of a single dose of recombinant Factor XIII in healthy volunteers
Gunneman T.	-	Precision of INR (International Normalized Ratio) measurement using laboratory and point-of-care assays: Understanding the impact of system influence on patient management
	-	Maintenance of patient vs. professional competence with patient self testing of the INR – a 6-year experience
	-	Reliability of patient self-testing and point-of-care testing with the Harmony (TM) INR monitoring system: a 3-year study
Gunther K. E.	-	Efficacy and safety of low dose vitamin K in outpatient management of patients with an INR > 10
Guo W. R.	-	The study on phenotype and genotype of Protein C in a Chinese family with hereditary Protein C deficiency
Guo Y.-L.	-	Apoptotic effect of cleaved high molecular weight kininogen is selectively regulated by extracellular matrix proteins
Guo H.	-	Protein S confers neuronal protection during ischemic/hypoxic injury in mice
Gupta K.	-	Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Gupta A.	-	Carboxy-terminal mutations render heparin cofactor II more susceptible to secretory impairment than equivalent mutations in antithrombin
Gurgey A.	-	Assessment of the role of various genetic risk factors in development of childhood cerebral thrombosis
Gurm H. S.	-	Does cyclooxygenase-2 have a role in aspirin-dependent platelet function?
Gursel T.	-	A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
Gusson P. R.	-	Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Gussoni G.	-	A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Gustafsson K.	-	Studies of blood coagulation and platelet function in thoracic surgery utilizing a point of care instrument, a free oscillation rheometer
Gustavsson L.	-	Characterization of the interaction of alpha-thrombin with melagatran analogs with different P3 substituents: a kinetic and thermodynamic study
Gutensohn K.	-	Transfusion of activated platelets: increase of platelet-leukocyte binding in vivo
	-	Monitoring platelet concentrates (PCs) during storage by functional and immunological tests
Güthner C.	-	Successful treatment with rituximab in a case of relapsed acquired hemophilia
Gutierrez M.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Gutiérrez-Fernandéz A	-	Regulation of plasminogen gene expression by nerve growth factor (NGF)
Gutnik L.	-	Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
	-	Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
Guyatt G.	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
Guzov I. I.	-	Inheritable thrombophilias in women with high risk of obstetric complications in the Moscow population
Gwyn G.	-	Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia
Gyotoku Y.	-	A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers
Gyzander E.	-	Characterization of the interaction of alpha-thrombin with melagatran analogs with different P3 substituents: a kinetic and thermodynamic study